Ahmed Bedjaoui
Overview
Explore the profile of Ahmed Bedjaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balayssac D, Kerckhove N, Selvy M, Pereira B, Gonneau C, Petorin C, et al.
Support Care Cancer
. 2024 Jun;
32(7):427.
PMID: 38869647
Purpose: Sensory chemotherapy-induced peripheral neuropathy (CIPN) is well-recognized, but motor CIPN remains understudied. This secondary analysis focused on the long-term severity and impact of motor disorders, their relation to sensory...
2.
Kerckhove N, Selvy M, Lambert C, Gonneau C, Feydel G, Petorin C, et al.
Front Pharmacol
. 2021 Nov;
12:744085.
PMID: 34803689
Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory...
3.
Selvy M, Pereira B, Kerckhove N, Gonneau C, Feydel G, Petorin C, et al.
J Clin Med
. 2020 Jul;
9(8).
PMID: 32727095
(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Little data are available on the long-term prevalence and consequences of chemotherapy-induced peripheral neuropathy (CIPN), even though the third largest...